Abstract 4226: Genome-wide CRISPRi screening identifies histone modification as a synergistic partner with JAK/STAT inhibition for enhancing anti-tumor activity in CTCL, validated in PDX-derived tumor cells
Year: 2025
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409635096
